RegulatoryMay 12, 2026, 11:02 AM
TNL Mediagene Receives Nasdaq Deficiency Letter for Equity Below $2.5M
AI Summary
TNL Mediagene announced it received a deficiency letter from Nasdaq on May 6, 2026, for failing to meet the minimum stockholders' equity requirement of $2.5 million. The company reported stockholders' equity of $918,088 as of December 31, 2025. This notification does not lead to immediate delisting, and TNL Mediagene has 45 days, until June 22, 2026, to submit a plan to regain compliance. The company is considering various options to maintain its Nasdaq listing.
Key Highlights
- TNL Mediagene received a Nasdaq Deficiency Letter on May 6, 2026.
- The company is non-compliant with Nasdaq Listing Rule 5550(b)(1) for failing to maintain $2.5 million in stockholders' equity.
- TNL Mediagene reported stockholders' equity of $918,088 as of December 31, 2025.
- The company has 45 calendar days (until June 22, 2026) to submit a compliance plan to Nasdaq.
- If the plan is accepted, TNL Mediagene may receive up to 180 calendar days to regain compliance.
- The deficiency letter does not result in immediate delisting of the company's ordinary shares.